RecallRadar

FDA Drug recall D-0517-2024

Metoprolol Tartrate Tablets USP, 25mg, 1000 count bottle, Rx only, distributed by: TruPharma, LLC, Tampa, FL 33609, Manufactured by: Rubico…

On 2024-06-05 the FDA classified a Class II recall of Metoprolol Tartrate Tablets USP, 25mg, 1000 count bottle, Rx only, distributed by: TruPharma, LLC, Tampa, FL 33609, Manufactured by: Rubico… by Rubicon Research Private, citing presence of Foreign Substance: metal in tablet.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0517-2024
ClassificationClass II
Statusongoing
Initiated2024-05-06
Published2024-06-05
Last updated2026-09-13 11:52 UTC
CompanyRubicon Research Private
DistributionUS

Product

Metoprolol Tartrate Tablets USP, 25mg, 1000 count bottle, Rx only, distributed by: TruPharma, LLC, Tampa, FL 33609, Manufactured by: Rubicon Research Private Limited, Ambernath Dist Thane 421506 India, NDC 52817-360-00

Reason

Presence of Foreign Substance: metal in tablet

Identifiers

ndc52817-362-10
ndc52817-362-00
ndc52817-359-10
ndc52817-359-50
ndc52817-361-10
ndc52817-361-00
ndc52817-360-10
ndc52817-360-00
ndc52817-358-10
ndc52817-358-50
code_infoLot 231037H1, exp 6/2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0517-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.